Plain-English translation of NCT04690972 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Researchers are building a collection of liver tissue samples from patients with chronic liver disease or liver cancer. By studying these samples in detail—especially looking at individual cells—scientists hope to better understand why these diseases develop, predict which patients will respond to treatment, and discover new ways to treat them.
Currently, there are no cures for advanced liver diseases like cirrhosis or certain types of liver cancer. One major reason is that doctors don't fully understand how these diseases work at the cellular level. By collecting and analyzing tissue samples in new ways, researchers hope to unlock the secrets of how liver disease progresses and find better, personalized treatments for patients.
You likely qualify if…
You likely don't qualify if…
If you qualify, your participation would involve donating liver tissue that is already being removed as part of your scheduled surgery, biopsy, or cancer treatment. You won't need extra visits or procedures—the tissue is collected during medical care you're already receiving. Researchers will then study your tissue samples using advanced techniques to understand your specific liver condition at the cellular level.
AI-generated summary from trial data · Jun 3, 2026 · Not medical advice
France
Sponsor
Institut National de la Santé Et de la Recherche Médicale, France
Enrollment target
~800 participants
Started
January 2021
Primary completion
January 2021
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
18 Years and older
Last updated on clinicaltrials.gov in February 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Thomas BAUMERT, DR
Institut National de la Santé Et de la Recherche Médicale, France
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.